Differential (Click to cross reference) advances in neurology Alberta Stroke Program Early CT score algorithm angiitis angiitis, granulomatous of CNS angiitis, isolated of CNS angiography, cerebral angiography, cerebral, negative anticoagulant, self-monitoring anticoagulant, treatment artificial intelligence ataxia benchmark bias billing biologic markers biological warfare black box brain biopsy callosal angle CAT scan CAT scan, abnormal CAT scan, angiography CAT scan, chest CAT scan, perfusion cerebrovascular accident cerebrovascular accident, acute management of cerebrovascular accident, nontreatment of cerebrovascular accident, prevention of cerebrovascular accident, secondary prevention chatbots chest x-ray chest x-ray, abnormal Clinical Pathologic Conference(C.P.C.) clinical reasoning cognition cognitive off-loading compliance complications computers, handheld computers, medicine and computers, neurologic diagnosis and confabulation consciousness controversies in neurology coronavirus COVID-19 craniectomy, decompressive critical thinking cyclophosphamide decision aids decision analysis deep learning deskilling diagnosis, difficult diagnostic uncertainty differential diagnosis differential diagnosis generators digital health digital health, wearable technology digital twins disinformation drug interactions efficacy electroencephalogram electroencephalogram, automated electroencephalogram, abnormalities of electronic differential diagnosis electronic health records emergencies, neurologic emergencies, neurosurgical encephalopathy encephalopathy, progressive endovascular therapy endovascular therapy, selection criteria EPIC electronic medical record epidemiology of neurology epilepsy ethics in neurology expert opinion false positive fundus, abnormality of funduscopic exam gait analysis technology gait disorder Generative Pretrained Transformer 4 hallucination headache headache, severe human extinction hydrocephalus hydrocephalus, normal pressure I don't know imbalance informatics information technology informed consent intellectual deterioration interobserver agreement intracerebral hemorrhage machine learning medical app medical education medical errors medical information medical record medical-legal aspects of neurology meningeal enhancement mental status, abnormal middle cerebral artery territory infarction, malignant middle cerebral artery, occlusion of misalignment misdiagnosis misinformation mis-skilling MRI MRI, abnormal MRI, angiography MRI, automated reading MRI, mismatch between DWI/FLAIR MRI, vessel wall enhancement neoplasm, metastatic neurologic complications neurologic consultation neurologic disease neurologic disease, burden neurologic disease, diagnoses of neurologic education neurologic examination neurologic examination, focal neurologic history neurologic practice NeurologicDx neurologist never-skilling ocular fundus photography oversight pandemic papilledema Parkinson disease patient information and support pitfalls posturography practice guidelines problem solving prognosis quality of care RAPID CT perfusion maps rapidly progressing neurologic illness real-world case recurrent review article risk factors risk-benefit assessment robotic therapy safety SCORE-AI screening seizure sentience shared decision making smartphone spinal cord, lesion of steroid therapy, CNS treatment and complications with stroke team telemedicine teleneurology telestroke treatment of neurologic disorder tumefactive lesion validation vasculitides verification videoconferencing virtual assistant virtual learning visual field defect walking, difficulty with workup Zeroth Law

Showing articles 100 to 112 of 112 << Previous 4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety Arch Neurol 51:292-296, Polman,C.H.,et al, 1994 The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover Neurol 44:1054-1059, Bever,C.T.,et al, 1994 The Effect of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis Ann Neurol 32:123-130, vanDiemen,H.A.M.,et al, 1992 4-Aminopyridine in Multiple Sclerosis:Prolonged Administration Neurol 41:1344-1348, Stefoski,D.,et al, 1991 Preliminary Trial of 3, 4-Diaminopyridine in Patients with Multiple Sclerosis Ann Neurol 27:421-427, Bever,C.T.,et al, 1990 Orally Administered 4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis Ann Neurol 27:186-192, Davis,F.A.,et al, 1990 3, 4-Diaminopyridine in the Treatment of Lambert-Eaton Myasthenic Syndrome NEJM 321:1567-1571, 1607-16081989., McEvoy,K.M.,et al, 1989 4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis Ann Neurol 21:71-77, Stefoski,D.,et al, 1987 Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease Neurol 37:1130-1134, Mayeux,R.,et al, 1987 The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP NEJM 312:1418-1421, Burns,R.S.,et al, 1985 Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission Neurol 31:265-271, Murray,N.M.F.,et al, 1981 Memory Impairment in Korsakoff's Psychosis:A Correlation with Brain Noradrenergic Activity Science 202:905-907, McEntee,W.J.,et al, 1978 4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome JNNP 40:1109, Lundh,H.,et al, 1977 Showing articles 100 to 112 of 112 << Previous